dat.lung: Example data set: Overall survival times in patients with...
In metamedian: Meta-Analysis of Medians
dat.lung R Documentation
Example data set: Overall survival times in patients with lung cancer
Description
A data set based on a meta-analysis comparing overall survival times between individuals randomized to experimental arms and comparator arms in randomized trials for non-small cell lung cancer therapies (Iskander et al. 2024).
Usage
dat.lung
Format
A data frame with 30 rows and 11 columns:
study National Clinical Trial (NCT) number of the study.
n.g1 number of subjects (experimental group).
med.g1 median overall survival (experimental group).
med.ci.lb.g1 lower confidence interval bound around the median (experimental group).
med.ci.ub.g1 upper confidence interval bound around the median (experimental group).
med.ci.level.g1 level of the confidence interval (experimental group).
n.g2 number of subjects (comparator group).
med.g2 median overall survival (comparator group).
med.ci.lb.g2 lower confidence interval bound around the median (comparator group).
med.ci.ub.g2 upper confidence interval bound around the median (comparator group).
med.ci.level.g2 level of the confidence interval (comparator group).
References
Iskander, R., Moyer, H., Fergusson, D., McGrath, S., Benedetti, A., and Kimmelman, J. (2024). The benefits and risks of receiving investigational solid tumor drugs in randomized trials: A systematic review and meta-analysis. Annals of Internal Medicine. 177(6)759-767.
metamedian documentation built on April 4, 2025, 3:47 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| dat.lung | R Documentation |
Example data set: Overall survival times in patients with lung cancer
Description
A data set based on a meta-analysis comparing overall survival times between individuals randomized to experimental arms and comparator arms in randomized trials for non-small cell lung cancer therapies (Iskander et al. 2024).
Usage
dat.lung
Format
A data frame with 30 rows and 11 columns:
study | National Clinical Trial (NCT) number of the study. |
n.g1 | number of subjects (experimental group). |
med.g1 | median overall survival (experimental group). |
med.ci.lb.g1 | lower confidence interval bound around the median (experimental group). |
med.ci.ub.g1 | upper confidence interval bound around the median (experimental group). |
med.ci.level.g1 | level of the confidence interval (experimental group). |
n.g2 | number of subjects (comparator group). |
med.g2 | median overall survival (comparator group). |
med.ci.lb.g2 | lower confidence interval bound around the median (comparator group). |
med.ci.ub.g2 | upper confidence interval bound around the median (comparator group). |
med.ci.level.g2 | level of the confidence interval (comparator group). |
References
Iskander, R., Moyer, H., Fergusson, D., McGrath, S., Benedetti, A., and Kimmelman, J. (2024). The benefits and risks of receiving investigational solid tumor drugs in randomized trials: A systematic review and meta-analysis. Annals of Internal Medicine. 177(6)759-767.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.